Select Asset Management & Trust acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 450 shares of the healthcare conglomerate’s stock, valued at approximately $226,000.
Other institutional investors have also made changes to their positions in the company. Assetmark Inc. grew its position in UnitedHealth Group by 5.2% in the 3rd quarter. Assetmark Inc. now owns 213,353 shares of the healthcare conglomerate’s stock valued at $83,366,000 after acquiring an additional 10,463 shares during the last quarter. Lincoln National Corp grew its position in UnitedHealth Group by 15.1% in the 4th quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock valued at $4,495,000 after acquiring an additional 1,174 shares during the last quarter. Dohj LLC grew its position in UnitedHealth Group by 4.2% in the 3rd quarter. Dohj LLC now owns 6,446 shares of the healthcare conglomerate’s stock valued at $2,968,000 after acquiring an additional 257 shares during the last quarter. YorkBridge Wealth Partners LLC grew its position in UnitedHealth Group by 1.8% in the 4th quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock valued at $7,681,000 after acquiring an additional 272 shares during the last quarter. Finally, Rafferty Asset Management LLC grew its position in shares of UnitedHealth Group by 52.5% during the 3rd quarter. Rafferty Asset Management LLC now owns 30,064 shares of the healthcare conglomerate’s stock worth $11,747,000 after buying an additional 10,349 shares in the last quarter. 86.07% of the stock is currently owned by institutional investors.
A number of equities analysts have recently issued reports on UNH shares. Wells Fargo & Company increased their price target on UnitedHealth Group from $565.00 to $613.00 and gave the stock an “overweight” rating in a research report on Friday, April 22nd. Credit Suisse Group increased their price target on UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a research report on Monday, April 18th. StockNews.com started coverage on UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Truist Financial increased their price target on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $482.00 to $549.00 and gave the company a “buy” rating in a research note on Monday, April 18th. Two research analysts have rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $550.17.
Shares of UnitedHealth Group stock traded down $15.87 on Friday, reaching $508.55. 2,873,166 shares of the stock were exchanged, compared to its average volume of 2,999,332. The company has a quick ratio of 0.79, a current ratio of 0.78 and a debt-to-equity ratio of 0.54. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The firm has a market capitalization of $477.50 billion, a price-to-earnings ratio of 27.84, a PEG ratio of 1.60 and a beta of 0.88. The business has a 50 day moving average price of $507.83 and a two-hundred day moving average price of $480.33.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping the Zacks’ consensus estimate of $5.38 by $0.11. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The firm had revenue of $80.15 billion during the quarter, compared to the consensus estimate of $78.77 billion. During the same quarter in the previous year, the company posted $5.31 earnings per share. The company’s revenue was up 14.2% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 22nd. Investors of record on Monday, March 14th were given a dividend of $1.45 per share. This represents a $5.80 annualized dividend and a yield of 1.14%. The ex-dividend date was Friday, March 11th. UnitedHealth Group’s dividend payout ratio is currently 31.75%.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.